Dr Deborah Jones joined the Dutch Resyca BV as CEO at the beginning of April, succeeding Remko Beimers, who has stepped down from his role.
ADVERTISEMENT
Tag Archive for: nasal spray
Leyden Labs has raised $70 million in a funding round led by ClavystBio and Polaris Partners, boosting its efforts to develop intranasal antibody therapies targeting respiratory viruses, including influenza and coronaviruses.


Resyca BV
robin_24, Wikipedia